Xeris Biopharma Holdings (XERS) EBIT Growth (3y) (2023 - 2026)
Xeris Biopharma Holdings (XERS) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 273.62% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.84% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 4.63% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 31.70% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 54.58% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 40.87% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -63.87% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 120.38% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -90.87% |
| 10 | Xeris Biopharma Holdings | 1.07 Bn | 954.87 Mn | 72.55 Mn | 37.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.44% |
| Dec 31, 2025 | 45.90% |
| Sep 30, 2025 | 33.11% |
| Jun 30, 2025 | 30.78% |
| Mar 31, 2025 | 52.63% |
| Dec 31, 2024 | 26.72% |
| Sep 30, 2024 | 19.11% |
| Jun 30, 2024 | 31.78% |
| Mar 31, 2024 | 5.24% |
| Dec 31, 2023 | 20.17% |
| Sep 30, 2023 | 29.03% |